Tag Archives: gastric cancer

October, 2018

June, 2018

January, 2018

December, 2017

July, 2017

  • 31 July

    FDA to Review Teva and Celltrion’s BLA for Proposed Biosimilar to Herceptin

    INCHEON, Republic of Korea & JERUSALEM–(BUSINESS WIRE)–Jul. 31, 2017– Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for CT-P6, a proposed Monoclonal Antibody (mAb) biosimilar to Herceptin®1 (INN: trastuzumab) which is used for the treatment of Human Epidermal …

April, 2015